At some stage I would suggest a US medical company could take a stake in PME.
The buying strength has been solid and consistent for some time now. Would not be surprised if another contract is not far away. Not cheap on fundamentals but the company has a lot of untapped business to be had if they continue to say ahead with their medical technology.
Ann: PAC Partners Conference Presentation, page-18
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$221.75 |
Change
7.130(3.32%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $216.99 | $224.65 | $215.12 | $38.21M | 172.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103 | $221.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $221.81 | 426 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
